Overview


Diabetes is a condition that lasts a lifetime and affects the way your body uses food to make energy. Your body turns most of the food that you eat into glucose, which is then released into your bloodstream. Your pancreas will release insulin if your blood sugar is high. Insulin acts as a key to allow blood sugar into your cells for use as fuel. Diabetes is when your body doesn’t make enough insulin or doesn’t use it properly. If your body doesn't make enough insulin, or your cells stop responding to insulin properly, then too much sugar stays in the bloodstream. That can lead to serious health problems such as heart disease and vision loss. Glucose provides energy to the cells that make the muscles and tissues. It's also the main fuel source in the brain. Type-specific diabetes is the main cause. However, no matter which type of diabetes you have it can cause excessive sugar in the blood. Excessive sugar can lead to serious health issues. Health problems can develop from too much glucose in the blood. You can manage diabetes and remain healthy, even though there is no cure.
Diabetes is one of the most prevalent chronic diseases in the world. When someone is diagnosed with diabetes, their glucose levels rise. This happens because the pancreas does not produce enough insulin. Type I diabetes is this type. Type II diabetes, on the other hand, is not responsive to insulin. The global diabetes management market is forecast to grow at a high rate over the next few years. Global diabetes management market growth is being driven by many factors. The growing prevalence of Type I and Type II Diabetes is the main driver for market growth. Global diabetes management is seeing significant growth due to this condition and the rise in obesity. Market development is being aided by the rising popularity of combination therapy over monotherapy. Due to its superior efficiency, combination therapy has become more popular. The growing collaborations and partnerships between leading players in diabetes management have also contributed to the growth of the global market. But, certain factors may prevent the global diabetes management industry from reaching its full potential. Market growth has been hampered by the widespread availability of counterfeit drugs. The market's growth is also likely to be hindered by the lack of proper healthcare infrastructure, and the absence of insurance benefits.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Diabetes Management Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Diabetes Management Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• Abbott Laboratories
• Bayer AG
• Bristol-Myers Squibb
• Eli Lilly and Co
• Sanofi
• Dexcom
• Medtronic
• Novo Nordisk A/S
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Device Type
• Monitoring Devices
o Blood Glucose Meters
o Lancets
o Blood Sampling Devices
• Diagnostic Devices
o Hemoglobin A1c
o hemoglobin A2c Kits
o hemoglobin A1c Meters
• Insulin Delivery Devices
o Insulin Pumps
o Insulin Pens
o Disposable Insulin Pens
o Insulin Syrines
o Reusable Insulin Pens
• Other Devices
o Artificial Pancreas
o Commercial Software
o Software Programs for Diabetes Monitoring
o Web Software
By Therapeutics
• Injectables
• Insulin
• Exenatide
• Oral Drugs
• Metformin
• Sulfonylureas
• Alpha glycosidase Inhibitors
• Dipeptidyl Inhibitors
• Meglitinides
• Thaizolidinediones
• Combination Medications
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Diabetes Management Market By Device Type, By Therapeutics and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Diabetes Management Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Device Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Diabetes Management Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Diabetes Management Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Device Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Device Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Diabetes Management Market, By Device Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Monitoring Devices
         1.1. Blood Glucose Meters
         1.2. Lancets
         1.3. Blood Sampling Devices
        2. Diagnostic Devices
         2.1. Hemoglobin A1c
         2.2. hemoglobin A2c Kits
         2.3. hemoglobin A1c Meters
        3. Insulin Delivery Devices
         3.1. Insulin Pumps
         3.2. Insulin Pens
         3.3. Disposable Insulin Pens
         3.4. Insulin Syrines
         3.5. Reusable Insulin Pens
        4. Other Devices
         4.1.Artificial Pancreas
         4.2.Commercial Software
         4.3.Software Programs for Diabetes Monitoring
         4.4.Web Software
  • 8.   Diabetes Management Market, By Therapeutics Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Injectables
        3. Insulin
        4. Exenatide
        5. Oral Drugs
        6. Metformin
        7. Sulfonylureas
        8. Alpha glycosidase Inhibitors
        9. Dipeptidyl Inhibitors
        10.Meglitinides
        11.Thaizolidinediones
        12.Combination Medications
  • 9.   North America Diabetes Management Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032
  • 10.   Latin America Diabetes Management Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032
  • 11.   Europe Diabetes Management Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032
  • 12.   Asia Pacific Diabetes Management Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032
  • 13.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032
  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bayer AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bristol-Myers Squibb
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Eli Lilly and Co
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sanofi
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Dexcom
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Medtronic
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Novo Nordisk A/S
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients